Effects of 5-HT(1A) receptor ligands in a modified Geller-Seifter conflict model in the rat

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages 121-128

  King, Christina M F ^a   Gommans, Jan ^a   Joordens, Rosemarie J E ^a   Hijzen, Theo H ^a   Maes, Robert A A ^a   Olivier, Berend ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

5 HT(1A) receptor; 8 OH DPAT (8 hydroxy 2 (di n propylamino)tetralin; Anxiety; Conflict; Flesinoxan; Geller Seifter; Rat; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; FLESINOXAN; LIGAND; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; QUINPIROLE; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONFLICT; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; PHYSIOLOGY; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ALPRAZOLAM; ANIMALS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; CONFLICT (PSYCHOLOGY); LIGANDS; MALE; PIPERAZINES; PYRIDINES; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030611697     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00114-3     Document Type: Article

References (35)

1. 1A agonist, in major depression: effects on sleep REM latency and body temperature. Hum. Psychopharmacol. Clin. Exp. 8, 279-283.
2. Barrett, J.E., Witkin, J.M., Mansbach, R.S., Skolnick, P., Weisman, B.A., 1986. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanism. J. Pharmacol. Exp. Ther. 238, 1009-1013.
3. 1A compound flesinoxan. J. Psychopharmacol. 3, 64-69.
4. Bendotti, C., Samanin, R., 1986. 8-Hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) elicits eating in free feeding rats by acting on central serotonin neurons. Eur. J. Pharmacol. 121, 147-150.
5. Bill, D.J, Knight, M., Forster, E.A., Fletcher, A., 1991. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT induced hypothermia. Br. J. Pharmacol. 103, 1857-1864.
6. Bradford, L.D., 1993. Flesinoxan treatment of generalized anxiety disorder: a fixed dose, placebo controlled study. J. Psychopharmacol. Suppl. A65.
7. Carlton, P.L., 1983. The Anxiolytics. In: Carlton, P.L. (Ed.), A Primer of Behavioural Pharmacology: Concepts and Principles in the Behavioural Analysis of Drug Action. W.H. Freeman and Company, New York, NY, pp. 175-191.
8. 1A receptors mediate the effect of ipsapirone on punished responding in rats. Eur. J. Pharmacol. 285, 249-255.
9. 1A receptor ligands in a safety signal withdrawal procedure of conflict in the rat. Pharmacol. Biochem. Behav. 48, 281-289.
10. Cook, L., Davidson, A., 1973. Effects of behaviourally active drugs in a conflict-punishment procedure in rats. In: Garattini, S., Mussini, E., Randall, L.O. (Eds.), The Benzodiazepines. Raven Press, New York, NY, pp. 327-345.
11. Davis, M., Cassella, J.V., Kehne, J.H., 1988. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology 94, 14-20.
12. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121, 1-26.
13. 1A receptor antagonist. Behav. Brain Res. 73, 337-353.
14. Geller, I., Seifter, J., 1960. The effect of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacology 1, 482-492.
15. Goa, K., Ward, A., 1986. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32, 114-129.
16. 1A receptor agonist, are not related to its neuroendocrine effects. Eur. J. Pharmacol. 280, 185-193.
17. 1A Receptors, Stress and Anxiety: Neuroendocrine and Behavioural Interrelationships. PhD Thesis, Utrecht University, Utrecht, pp. 79-93.
18. Groenink, L., Van der Gugten, J., Compaan, J.C., Maes, R.A.A., Olivier, B., 1997. Flesinoxan pretreatment differentially affects prolactin, corticosterone and behavioural response to a flesinoxan challenge. Psychopharmacology (in press).
19. 1A receptor agonist, in treatment resistant depression. Int. Clin. Psychopharmacol. 8, 167-172.
20. Hutson, P.H., Dourish, C.T., Curzon, G., 1986. Neurochemical and behavioral evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur. J. Pharmacol. 129, 347-352.
21. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272, 920-929.
22. Joordens, R.J.E., Hijzen, T.H., Peeters, B.W.M.M., Olivier, B., 1996. Fear-potentiated startle response is remarkably similar in two laboratories. Psychopharmacology 126, 104-109.
23. Kalkman, H.O., 1990. Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment with para-chlorophenylalanine. Psychopharmacology 101, 39-42.
24. Mansbach, R.S., Harrod, C., Hoffmann, S.M., Nader, M.A., Lei, Z., Witkin, J.M., Barrett, J.E., 1988. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeon of drugs that increase punished responding. J. Pharmacol. Exp. Ther. 246, 114-120.
25. 1A agonists. Mol. Pharmacol. 37, 231-237.
26. Olivier, B., Molenwijk, E., Van Oorschot, R., Van der Poel, G., Zethof, T., Van der Heijden, J., Mos, J., 1994. New animal models of anxiety. Eur. Neuropsychopharmacol. 4, 93-102.
27. 1A antagonist that blocks the discriminative stimulus and response rate effects of 8-OH-DPAT in rats. Soc. Neurosci. Abstr. 20, 377.
28. Pollard, G.T., Howard, J.L., 1990. Effects of drugs on punished behaviour: preclinical test for anxiolytics. Pharmacol. Ther. 45, 403-424.
29. Sanger, D.J., 1990. Effects of buspirone and related compounds on suppressed operant responding in rats. J. Pharmacol. Exp. Ther. 254, 420-426.
30. Schipper, J., Tulp, J., Berkelmans, B., Van der Heijden, J., Olivier, B., 1991. Preclinical pharmacology of flesinoxan: a potential anxiolytic and antidepressant drug. Hum. Psychopharmacol. 6, S53-S61.
31. 1A receptor agonists 8-OH-DPAT, ipsiparone and buspirone in the rat. Eur. J. Pharmacol. 249, 341-351.
32. Taylor, D.P., Eison, M.S., Riblet, L.A., Vandermaelen, C.P., 1985. Pharmacologic and clinical effects of buspirone. Pharmacol. Biochem. Behav. 23, 687-694.
33. Ybema, C., Slangen, J.L., Olivier, B., Mos, J., 1990. Discriminative stimulus properties of flesinoxan. Pharmacol. Biochem. Behav. 35, 781-784.
34. Young, R., Urbanic, A., Emrey, T.A., Hall, P.C., Metcalf, G., 1987. Behavioral effects of several new anxiolytics and putative anxiolytics. Eur. J. Pharmacol. 143, 361-371.
35. Zethof, T., Van der Heyden, J., Tolboom, J., Olivier, B., 1995. Stress-induced hyperthermia as a putative anxiolytic model. Eur. J. Pharmacol. 294, 125-135.